A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

WEDNESDAY, Nov. 12, 2024 (HealthDay News) -- Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study reports. Procedures like radiation ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Prostate cancer is the most common cancer in American men, with an estimated 333,830 new cases and 36,320 deaths projected for 2026 for the disease, according to the American Cancer ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

The city says it will devote $2 million to improve health outcomes, including for Black men in particular, who have Boston’s lowest life expectancy.